Morii H - Search Results

1

Circulating bone Gla protein in end-stage renal disease determined by newly developed two-site immunoradiometric assay.

Nakatsuka K, Miki T, Nishizawa Y, Tabata T, Inoue T, Morii H, Ogata E. Nakatsuka K, et al. Among authors: morii h. Contrib Nephrol. 1991;90:147-54. doi: 10.1159/000420137. Contrib Nephrol. 1991. PMID: 1959340

2

Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus.

Emoto M, Tabata T, Inoue T, Nishizawa Y, Morii H. Emoto M, et al. Among authors: morii h. Nephron. 1992;61(2):181-6. doi: 10.1159/000186868. Nephron. 1992. PMID: 1630543

3

Clinical trial of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 in uremic patients on hemodialysis: preliminary report.

Nishizawa Y, Morii H, Ogura Y, De Luca HF. Nishizawa Y, et al. Among authors: morii h. Contrib Nephrol. 1991;90:196-203. doi: 10.1159/000420143. Contrib Nephrol. 1991. PMID: 1659967 Clinical Trial.

4

Effect of intermittent oral 1,25(OH)2D3 therapy on bone Gla protein in dialysis patients.

Miki T, Nakatsuka K, Nishizawa Y, Emoto M, Morita A, Tabata T, Matsushita Y, Inoue T, Morii H. Miki T, et al. Among authors: morii h. Endocrinol Jpn. 1991 Oct;38(5):479-83. doi: 10.1507/endocrj1954.38.479. Endocrinol Jpn. 1991. PMID: 1843267 Free article.

5

Parathyroid hormone secretion in diabetes mellitus.

Kawagishi T, Morii H, Nakatsuka K, Sasao K, Kawasaki K, Miki T, Nishizawa Y. Kawagishi T, et al. Among authors: morii h. Contrib Nephrol. 1991;90:217-22. doi: 10.1159/000420146. Contrib Nephrol. 1991. PMID: 1959350

6

Decreased bone mineral density in diabetic patients on hemodialysis.

Nishitani H, Miki T, Morii H, Nishizawa Y, Ishimura E, Hagiwara S, Nakatsuka K, Yamakawa M. Nishitani H, et al. Among authors: morii h. Contrib Nephrol. 1991;90:223-7. doi: 10.1159/000420147. Contrib Nephrol. 1991. PMID: 1959351

7

Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients.

Shoji T, Nishizawa Y, Kawagishi T, Kawasaki K, Taniwaki H, Tabata T, Inoue T, Morii H. Shoji T, et al. Among authors: morii h. J Am Soc Nephrol. 1998 Jul;9(7):1277-84. doi: 10.1681/ASN.V971277. J Am Soc Nephrol. 1998. PMID: 9644639 Clinical Trial.

8

Vitamin K(2) (menaquinone 4) reduces serum undercarboxylated osteocalcin level as early as 2 weeks in elderly women with established osteoporosis.

Miki T, Nakatsuka K, Naka H, Kitatani K, Saito S, Masaki H, Tomiyoshi Y, Morii H, Nishizawa Y. Miki T, et al. Among authors: morii h. J Bone Miner Metab. 2003;21(3):161-5. doi: 10.1007/s007740300025. J Bone Miner Metab. 2003. PMID: 12720050 Clinical Trial.

9

A two-site immunochemiluminometric assay for intact parathyroid hormone and its clinical utility in hemodialysis patients.

Morita A, Tabata T, Koyama H, Emoto M, Inoue T, Miki T, Nishizawa Y, Morii H. Morita A, et al. Among authors: morii h. Clin Nephrol. 1992 Sep;38(3):154-7. Clin Nephrol. 1992. PMID: 1395169

10

High serum lipoprotein(a) concentrations in uremic patients treated with continuous ambulatory peritoneal dialysis.

Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H. Shoji T, et al. Among authors: morii h. Clin Nephrol. 1992 Nov;38(5):271-6. Clin Nephrol. 1992. PMID: 1451340

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

566 results

Search Page

Filters